SLN and NLC for topical, dermal, and transdermal drug delivery (2020)
Souto, Eliana B.; Baldim, Iara 
; Oliveira, Wanderley Pereira de ; Rao, Rekha; Yadav, Nitesh; Gama, Francisco M.; Mahant, Sheefali
Fonte: Expert Opinion on Drug Delivery. Unidade: FCFRP
Assuntos: NANOPARTÍCULAS, LIPÍDEOS, PELE, SURFACTANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUTO, Eliana B. et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opinion on Drug Delivery, v. 17, n. 3, p. 357-377, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425247.2020.1727883. Acesso em: 03 nov. 2024.APA
Souto, E. B., Baldim, I., Oliveira, W. P. de, Rao, R., Yadav, N., Gama, F. M., & Mahant, S. (2020). SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opinion on Drug Delivery, 17( 3), 357-377. doi:10.1080/17425247.2020.1727883NLM
Souto EB, Baldim I, Oliveira WP de, Rao R, Yadav N, Gama FM, Mahant S. SLN and NLC for topical, dermal, and transdermal drug delivery [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 3): 357-377.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1080/17425247.2020.1727883Vancouver
Souto EB, Baldim I, Oliveira WP de, Rao R, Yadav N, Gama FM, Mahant S. SLN and NLC for topical, dermal, and transdermal drug delivery [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 3): 357-377.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1080/17425247.2020.1727883
